Integra LifeSciences (IART) Tops Q3 EPS by 1c, Updates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Integra LifeSciences Reports Third Quarter 2015 Financial Results
November 3, 2015 6:00 AM ESTRevenue Increased 14.6% to $226.4 Million with Adjusted EPS of $0.75
Adjusted Net Income Increased 15.1%
Raised Low End of Full Year 2015 Revenue and EPS Guidance
PLAINSBORO, N.J., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today reported its financial results for the third quarter ending September 30, 2015.
Highlights:Â
Third quarter revenue increased 14.6% over the prior year quarter to $226.4 million and organic revenue increased... More